As a well-recognized expert in the field of next generation sequencing (NGS) based cancer research, Creative Biolabs offers our worldwide clients high-quality and comprehensive NGS solutions to advance the progression of cancer research. We have equipped a world-leading high-throughput sequencing platform including Illumina HiSeq X Ten, Illumina HiSeq, Illumina MiSeq, and Ion PGM™, which meets requirements for various sequencing projects. Our strict sequencing process and quality control enable to deliver reliable and accurate data. Besides, we have also organized an excellent scientist team who can customize an optimal bioinformatic analysis solution according to the requirements of your project. With a professional expert team and capabilities ranging from preparation of nucleic acid samples, library construction and sequencing to data QC and analysis, we are dedicated to supporting a series of high-throughput sequencing and analysis services to advance the progress of cancer research.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM